CREDIT REPORT |
|
|
| © Coface Slovenija Credit Management Services
d.o.o. email: office@coface.si 11.12.2005 15:36 |
|
|
| COMPANY REPORTED: | LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH
IZDELKOV, D.D.
Principal Address: VEROVŠKOVA 57 1000 LJUBLJANA SLOVENIA Tel: +386-1-580 21 11 Fax: +386-1-568 35 17 Email: info@lek.si Internet: www.lek.si National ID: 5043425 VAT number: 94471568 |
|
|
| Information valid on: | 11.12.2005 |
|
|
| ESTABLISHED: | 1964 |
|
|
| REGISTRATION: | No. 1/00253/00
1964 Ljubljana, SLOVENIA |
|
|
| LEGAL FORM: | joint stock company |
|
|
| CAPITAL: | SIT 11599056 Thousand |
|
|
| SHAREHOLDERS: | Servipharm AG,c/o Novartis Pharma AG REGISTRATION: SWITZERLAND 4056 Basel, Lichstrasse 35 Shareholder EQUITY: 99% OSTALI DELNIČARJI/ANDERE AKTIONERE/ OTHER SHAREHOLDERS REGISTRATION: SLOVENIA Shareholder EQUITY: 1% |
|
|
| MANAGEMENT: | METOD DRAGONJA - Manager The company NOVARTIS from Ch became the major shareholder in November 2002 |
|
|
| REPRESENTATION: | Moskwa, Kiev, Warschaw, New York, Paris, RIGA etc |
|
|
| SUBJECT OF OPERATION: | -production of medicines, chemicals, different chemical products, cosmetics |
|
|
| IMPORTS: |
|
|
|
| EXPORTS: |
USA,J,GB,RUS, Nigeria, D, PL, Lithuania, CRO, etc. |
|
|
FINANCIALS:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Approximate exchange rates: | 2001: 220,7453 SIT = 1 EUR 2001: 250,9458 SIT = 1 USD |
|
|
| RATE OF EXCHANGE: | 2000: 105 SIT = 1 DEM 1999: 100 SIT = 1 DEM 1998: 94 SIT = 1 DEM |
|
|
| WORKFORCE: |
|
|
|
| LIABILITIES: |
|
|
|
| REAL ESTATE: | The company has production facilities on diferent places: Ljubljana, Mengeš, Lipovci, Kranjska gora, Prevalje, Lendava, Ljubljana-Šiška, |
|
|
| RELATED FIRMS: | Shareholder HOTEL LEK, DEJAVNOST HOTELOV, D.O.O., KRANJSKA GORA 4280 KRANJSKA GORA, VRŠIŠKA CESTA 38 EQUITY: 100% Shareholder LEK KIEW EQUITY: 100% Shareholder LEK BH SARAJEVO EQUITY: 100% Shareholder LEK KOZMETIKA, PROIZVODNJA KOZMETIČNIH PROIZVODOV, D.O.O. LJUBLJANA 1000 LJUBLJANA, Verovškova 57 EQUITY: 100% Shareholder LEK PHARMA s.r.o. Praga EQUITY: 100% Shareholder LEK PHARMACEUTICALS INC EQUITY: 100% Shareholder LEK POLEN EQUITY: 100% Shareholder LEK s.r.o. 821 02 Bratislava, Ružinovská 1 EQUITY: 100% Shareholder LEK SERVICES INC. us EQUITY: 100% Shareholder LEK SOFIA EQUITY: 100% Shareholder LEK ZAGREB prodaja farmaceutskih i kemijskih proizvoda, d.o.o. EQUITY: 100% Shareholder LEK ZAO MOSKVA EQUITY: 100% Shareholder Zakład Farmaceutyczny Argon S.A. 90-972 Łódź, ul. Sarnia 3/5 EQUITY: 100% Daughter company Lek Ljubljana Holding GmbH EQUITY: 100% Daughter company LEK NS d.o.o. Beograd EQUITY: 100% Daughter company LEK PHARMA UK Ltd EQUITY: 100% Shareholder LEK ASIA EQUITY: 99,99% Shareholder LEK SKOPJE EQUITY: 99,99% Shareholder LEK PHARMATECH SRL 4300 Targu Mures, jud. Mures, Livezeni 4 EQUITY: 90% Shareholder ČISTILNA NAPRAVA LENDAVA D.O.O. EQUITY: 74,5% Shareholder LEKIS D.O.O. PODJETJE ZA RAČUNALNIŠKI INŽENIRING IN TRGOVINO 2000 MARIBOR, STROSSMAYERJEVA 26 EQUITY: 60% Shareholder TAYLEK DRUGS EQUITY: 60% Shareholder BAYER PHARMA TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV D.O.O. LJUBLJANA 1000 LJUBLJANA, CELOVŠKA 135 EQUITY: 51% Shareholder SanofiSynthelabo-Lek d.o.o. Ljubljana EQUITY: 49% Shareholder KEMOFARMACIJA VELETRGOVINA ZA OSKRBO ZDRAVSTVA D.D. LJUBLJANA 1000 LJUBLJANA, CESTA NA BRDO 100 EQUITY: 31,4% |
|
|
| BANKERS: | ABANKA D.D.LJUBLJANA - Account no.
05100-8000005424 1000 LJUBLJANA, SLOVENSKA CESTA 58 NOVA LJUBLJANSKA BANKA D.D., LJUBLJANA - Account no. 02923-0012224080 1000 LJUBLJANA, TRG REPUBLIKE 2 SKB BANKA D.D. LJUBLJANA - Account no. 03100-1005938988 1000 LJUBLJANA, AJDOVŠČINA 4 |
|
|
| DATES: | date of validity: 11.02.2003 date of last record maintenance: 11.02.2003 |
|
|
| PAYMENT MORALE: | 200: Active firm's payments are made using cash
discounts or according to conditions. |
|
|
| CREDIT RATING: | 150: Financial situation is very good. |
|
|
| DEBT COLLECTION: | There is no record of any debt collection action by Coface Intercredit against this company |
|
|
| MAXIMUM CREDIT: | EUR 2 Million |
|
|
| Maximum Credit is to be understood as the highest possible engagement for a supplier delivering goods or rendering services on open terms with an average respite of 60 days. (It is assumed that, on the average, the company in question has 5 suppliers, who deliver goods or render services at the same time.) |
|
|
| PAYMENT MORALE | CREDIT RATING | |||
| 100-149 | Payments are made very correctly. | Financial situation is excellent. | ||
| 150-199 | Payments are made correctly. | Financial situation is very good. | ||
| 200-249 | Payments are sometimes made using cash discounts or according to conditions. | Financial situation is good. | ||
| 250-299 | Payments are made within net agreements. | Financial situation is satisfactory. | ||
| 300-349 | As a rule payments are made on time according to conditions, in some cases there have been delays and reminders. | Financial situation is average. | ||
| 350-399 | Payments are made irregularly, sometimes according to agreements. In several cases reminders have been necessary. | Financial situation is average, increased use of external capital. | ||
| 400-449 | Payments are made very slowly. | Overall financial situation is still average. | ||
| 450-499 | Payments are made very slowly. collection procedures cannot be ruled out. | Financial situation is temporarily critical. | ||
| 500-549 | Payments are made very slowly, reminders are often necessary. There have also been collection procedures. | Financial situation is critical. | ||
| 550-599 | Payments are made very slowly. There have been frequent collection procedures. | Financial situation is very critical. | ||
| 600-699 | Payments are made extremely slowly. There have been frequent collection procedures. | High risk of bankruptcy. |
|
|
| End of document. |